TITLE

Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD

AUTHOR(S)
Poirier, Paul; Brooks, M. M.
PUB. DATE
October 2009
SOURCE
ACP Journal Club;10/20/2009, Vol. 151 Issue 4, p3
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses a study on the relation between prompt revascularization (PR) in medical therapy (MT) and mortality or cardiovascular (CV) events in patients with type 2 diabetes and coronary artery disease (CAD). The results of the study indicate a 30% relative reduction in mortality from 14% to 9.8%. Further, a difference was also found in the trials indicating a difference in the effects of PR and MT in major CV events.
ACCESSION #
45383389

 

Related Articles

  • Enhancing macrovascular outcomes in DM2. Kuritzky, Louis // Clinical Oncology Alert;Aug2009 Supplement, p15 

    The article discusses research which investigated the outcome of various therapies in a group of patients with type 2 diabetes mellitus (DM2) with established coronary artery disease (CAD). It references a study published in the "New England Journal of Medicine." The therapies investigated...

  • Aggressive BP control can boost CV risk in diabetes.  // GP: General Practitioner;6/26/2009, p17 

    The article offers information on the impact of aggressive blood pressure (BP) reduction in people on cardiovascular (CV) risk among patients with type-2 diabetes. According to an analysis discussed in the article, aggressive BP lowering can raise the risk of cardiovascular events among those...

  • The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population. Jung, Chang Hee; Seo, Gi Hyeon; Suh, Sunghwan; Bae, Ji Cheol; Kim, Mee Kyoung; Hwang, You-Cheol; Kim, Jae Hyeon; Lee, Byung-Wan // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Background: Whether diabetic patients without a history of coronary heart disease (CHD) have the same risk of CHD events as non-diabetic patients with a history of CHD remains controversial. This study aimed to determine whether type 2 diabetes mellitus (T2DM) is a coronary heart disease (CHD)...

  • CITATIONS AND CLINICIANS' NOTES: COMPLICATIONS OF DIABETES -- NEPHROPATHY.  // Current Medical Literature: Diabetes;2005, Vol. 22 Issue 2, p38 

    Discusses a study on the association between renal disease in patients with type 2 diabetes and increased mortality risk. Markers of renal disease that were used on the study; Strong association of hazard ratios with coronary artery disease; Indication that any measure of renal disease in type 2...

  • How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with Type 2 Diabetes? Doggrell, Sheila A. // Vascular Disease Prevention;Oct2006, Vol. 3 Issue 4, p335 

    Type 2 diabetes (DM) increases the risk of coronary heart disease (CHD) by a factor of 2 to 4. In the Scandinavian Simvastatin Survival Study, 483 of the enrolled 4444 patients with CHD also had type 2 DM. Simvastatin (20-40 mg/day) decreased low density lipoprotein (LDL) cholesterol by 35% and...

  • When it comes to diabetes, women are at a distinct disadvantage.  // Contemporary OB/GYN;Apr2006, Vol. 51 Issue 4, p16 

    Reports on the results of a meta-analysis and a study conducted by two groups of researchers, one from Australia, regarding the distinct advantage of women with type 2 diabetes mellitus in terms of fatality rate in 2006. Possibility of men with diabetes to die from the disease than the women;...

  • Heart Rate Recovery After Exercise Is a Predictor of Silent Myocardial Ischemia in Patients With Type 2 Diabetes. YAMADA, TOMOHIDE; YOSHITAMA, TAKASHI; MAKINO, KUNIHIKO; TETSUO LEE; SAEKI, FUMIHIKO // Diabetes Care;Mar2011, Vol. 34 Issue 3, p724 

    OBJECTIVE--Slow heart rate recovery, (HRR) predicts all-cause mortality. This study investigated the relationship between silent myocardial ischemia (SMI) and HRR in type 2 diabetes. RESEARCH DESIGN AND METHODS--The study enrolled 87 consecutive patients with type 2 diabetes and no chest...

  • The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality. Fox, Caroline S.; Sullivan, Lisa; D'Agostino Sr., Ralph B.; Wilson, Peter W. F. // Diabetes Care;Mar2004, Vol. 27 Issue 3, p704 

    The risk of coronary heart disease (CHD) in type 2 diabetes is two- to threefold higher than in the general population, but the effect of diabetes duration on CHD risk has not been well characterized. We hypothesized that duration of diabetes is an important predictor of incident CHD among...

  • Use of Thiazolidinediones and Risk of Heart Failure in People With Type 2 Diabetes: A Retrospective Cohort Study. Karter, Andrew J.; Ahmed, Ameena T.; Liu, Jennifer; Moffet, Howard O.; Parker, Melissa M.; Ferrara, Assiamira; Selby, Joe V. // Diabetes Care;Mar2004, Vol. 27 Issue 3, p850 

    Presents a comment on the study determining the effects of thiazolidinedione drugs on patients with type 2 diabetes. Increase on the risks of coronary heart disease; Factors influencing the rise on the level of mortality rate; Survival of the patients.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics